Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sutent in Metastatic Melanoma Patients With KIT Aberrations
NCT00631618Phase 2Completed
- Sponsor
- California Pacific Medical Center Research Institute
- Start
- Sep 2007
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in melanoma, sponsored by California Pacific Medical Center Research Institute. Started Sep 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00631618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00631618.